Expect Patients to Use CGM Devices Earlier in Diabetes

April 2026

You’ll start to see earlier use of continuous glucose monitoring (CGM) devices in patients with diabetes.

Am Diabetes Assoc (ADA) guidelines now recommend CGM at diagnosis or anytime after for patients on insulin or other meds that can cause low blood sugar (glipizide, etc)...or whenever CGM can help with management.

That’s because early initiation improves blood sugar control (A1c) and limits episodes of dangerously low blood sugar (hypoglycemia).

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Diabetes Expect Patients to Use CGM Devices Earlier in Diabetes
Rumor vs Truth Sort Out Fact From Fiction Around Antimicrobial Stewardship
Practice Don’t Let Return-to-Stocks Become “Return-to-Risk”
Pregnancy & Nursing Listen for Questions About GLP-1 Use in Breastfeeding
Gastroenterology Look for Unusual Erythromycin Rxs for Gastroparesis
Liver Disease Watch for Injectable Semaglutide to Treat Fatty Liver
Pediatrics Prevent Mix-Ups With Baby Formulas
NatMed Spotlight Help Weigh Pros and Cons of Popular Sleep Supplements

Expect Patients to Use CGM Devices Earlier in Diabetes

Practical advice for a better career, with unlimited access to CE

Table of Contents